Skip to content

Nisha Jain

Nisha Jain

Company: Bioverativ, a Sanofi Company

Job title: Executive Medical Director


Data from a Prospective Study using FVIIIFc for ITI in Hemophilia Patients with Inhibitors 1:00 pm

Interim data from an ongoing studying Predicting responders and non-responders Role of high dose in tolerization successRead more

day: Day Two

Understanding Immunogenicity in Next Generation Factor Replacement Prophylaxis
9:00 am - 12:00 pm

Novel therapeutic strategies have been able to gradually improve the standard of care of hemophilia treatments. The major barrier to the success of this is the development of inhibitor in the patients. Attending this workshop will help you understand how immunogenicity risk assessment studies and real world data can help you to understand the why…Read more

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.